German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve.
Horstkotte
D
D
Heinrich-Heine-University, Düsseldorf, F.R. Germany.
Bergemann
R
R
Althaus
U
U
Babin-Ebell
J
J
Chares
M
M
Dahm
M
M
Eigel
P
P
Elert
O
O
Emmrich
K
K
Geiger
A W
AW
D000074:Acenocoumarol / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001021:Aortic Valve / Q000601:surgery*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005858:Germany; D006349:Heart Valve Diseases / Q000097:blood / Q000401:mortality / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D010644:Phenprocoumon / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D011183:Postoperative Complications / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D011446:Prospective Studies; D015996:Survival Rate; D013923:Thromboembolism / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics
D000925:Anticoagulants; D014859:Warfarin; D000074:Acenocoumarol; D010644:Phenprocoumon